Lilly Obesity Shot Zepbound Officially in Shortage, FDA Says (1)

Eli Lilly & Co.’s weight-loss drug Zepbound is officially in shortage in the US, after mounting complaints by patients, doctors and pharmacists who are having trouble finding the drug.

Two doses of the medicine will be limited in their availability through the end of April, according to a US Food and Drug Administration webpage updated Wednesday. The supply constraint is caused by increased demand, according to the agency.

Lilly’s shares rose 1.4% as of 11:56 a.m., paring earlier gains. A spokesperson for Lilly didn’t immediately respond to a request for comment.

In recent weeks, dozens of patients have told ...